What is the long-term trend for Innovate's total cash, cash equivalents, and restricted cash (inclusive)?

Over 2 years (2020 to 2025), Innovate's total cash, cash equivalents, and restricted cash (inclusive) has grown at a -24.1% compound annual growth rate (CAGR), from $195.4M to $112.7M.

Innovate VATE Total Cash, Cash Equivalents, and Restricted Cash (Inclusive)

Total Cash, Cash Equivalents, and Restricted Cash (Inclusive) at other companies

Optex Systems HoldingsOPXS

$4.16M+17.9%

Xtant Medical HoldingsXTNT

$12.16M+124%

Strawberry FieldsSTRW

$69.66M-2.0%

Inter ParfumsIPAR

$158.09M+26.0%

MarketAxessMKTX

$548.24M-14.9%

Where Food Comes FromWFCF

$3.28M+46.6%

Other financials

Income statement

See full

Revenue$364.8M+33.0%

Gross profit$53.5M+17.6%

Operating income$10.0M+194%

Net income-$16.8M+31.4%

EPS (diluted)-$1.29+31.7%

Balance sheet

See full

Cash & equivalents$134.6M+297%

Total debt$1.4B+11.6%

Total equity-$256.3M-25.5%

Total assets$936.8M+7.9%

Cash flow

See full

Operating cash flow$45.5M+423%

CapEx$200.0K-95.7%

Free cash flow$45.3M+341%

Valuation

See full

Market cap$254.69M+274%

Where this comes from

Reported directly by Innovate in its filing.

Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations.

The official record: Innovate’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Innovate's total cash, cash equivalents, and restricted cash (inclusive).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Innovate's total cash, cash equivalents, and restricted cash (inclusive)?: Innovate (VATE) reported total cash, cash equivalents, and restricted cash (inclusive) of $135.2M in Q1 2026.
What is the long-term trend for Innovate's total cash, cash equivalents, and restricted cash (inclusive)?: Over 2 years (2020 to 2025), Innovate's total cash, cash equivalents, and restricted cash (inclusive) has grown at a -24.1% compound annual growth rate (CAGR), from $195.4M to $112.7M.